60 DEGREES PHARMACEUTICALS - COMPANY TO UNBLIND RANDOMIZED PLACEBO-CONTROLLED STUDY OF TAFENOQUINE IN BABESIOSIS IN JANUARY 2027

Reuters · 2d ago

Please log in to view news